Groff North America partners with Pennsylvania college for first-of-its-kind cannabinoid major

PUBLISHED Mar 31, 2022
a hand holding a groff sample with a groff north america lab jacket on

FOR IMMEDIATE RELEASE

CONTACT: Amanda Peterson Martin
apmartin@gavinadv.com
484-949-1320

Groff North America partners with Pennsylvania college for first-of-its-kind cannabinoid major
Students will have access to products, internships to advance cannabis research, job training

RED LION, Pa. – (March 24, 2022) – As the medicinal and recreational marijuana industries continue to grow, so does the need for trained professionals. Groff North America is thrilled to announce it has partnered with York College of Pennsylvania to prepare the next generation of chemists for careers in cannabis, who can graduate with a degree in Cannabinoid Chemistry.

Groff North America is an industry leader, one of five in the nation approved to hold schedule 1 registrations for testing and research of marijuana.

“Being located in York County, Pennsylvania and so close to York College, it’s truly a huge opportunity for students, for education, for science, for training, job creation,” says Groff North America founder Dr. Steven Groff.

The Cannabinoid Chemistry program is the first of its kind in Pennsylvania and within the mid-Atlantic region. York College students will achieve a Bachelor of Science, specializing in natural production extraction, purification and analysis.

“Groff North America is internationally known for their leading work in extraction of cannabinoids from hemp and medical cannabis,” said Jessica Fautch, associate professor and chair of the Chemistry Department. “As a global leader in cannabinoid research, Groff NA will inspire and drive publication-quality collaborative research with York College faculty and students.”

Groff North America will mentor students and provide internships starting fall 2022.

ABOUT GROFF NORTH AMERICA
Groff North America is a physician-owned cannabis cultivation, extraction and formulation company based in South Central, PA. Founded by Steve Groff, M.D. and lead by Joe Grzyb, CEO, Groff NA cultivates, processes, and refines both cannabis and hemp with a commitment to provide quality, consistent, sustainable, and trusted cannabis products to businesses and researchers who are registered to handle Schedule 1 drugs. Groff NA is one of three commercially focused companies with Schedule 1 registrations from the U.S. Drug Enforcement Administration for bulk cultivation of marijuana and the only company to further possess registration for patient dose manufacturing. Groff NA also has registrations, as cannabis exporter, importer, researcher, and analytical lab. In December of 2021, aided by the collaboration and cultivation expertise of Brighterside Vertical Farms, Groff NA’s cultivation facility yielded a highly successful first harvest of high quality, medical-grade cannabis. In February 2022, Groff NA completed the first legal transfer/ buy-back transaction of domestically cultivated marijuana with the DEA, allowing Groff NA to manufacture and sell its cannabis products for federally authorized research, drug development, drug manufacturing and export. With its seed-to-shelf approach and commitment to technology and human capital, Groff NA develops products to support customers in the advancement of cannabis-based medicine.

Suggested reads

Apr 20, 2022
Can DEA-backed cannabis growers strike gold via drug development?
Can DEA-backed cannabis growers strike gold via drug development? The cannabis industry hit a possible milestone in March when Bright Green Corp., a Florida Read more
Mar 04, 2022
How will Groff North America cannabis products be developed from research to market as medicines?
How will Groff North America cannabis products be developed from research to market as medicines? CEO Joe Gryzb talked to Harri Leigh of WPMT FOX43 about the potenti Read more
Mar 03, 2022
We are making history at Groff North America!
We are making history at Groff North America. After 53 years, we are one of five companies approved to grow and study cannabis for medical research in the U.S. WPMT Read more
Mar 02, 2022
The transition from medical marijuana to cannabis-based pharmaceutical drugs | Little Green Pill
We know cannabis has powerful potential medical effects. Groff North America is proud to be producing research-grade marijuana, so we can continue growing the field Read more
Feb 23, 2022
Groff North America makes historic cannabis transaction with DEA
FOR IMMEDIATE RELEASE CONTACT:       Jay Scott jscott@gavinadv.com 484-695-3774   Groff North America makes historic cannabis transactio Read more